Health Technology Assessment (HTA)

Amid increasing calls for advancements in medical technology evaluation processes, the Korea Health Industry Development Institute (NECA) has stepped up to host a vital...

Austria is spearheading an innovative approach to healthcare with the development of a programme theory for social prescribing (SP) in primary care environments. Implemented...

The German Federal Joint Committee (G-BA) has embarked on a groundbreaking path by initiating a procedure aimed at requiring supplementary data collection for the...

Across Europe, the challenge of swiftly delivering innovative cancer therapies into the hands of patients exacerbates the stark realities of unmet medical needs within...

In the rapidly advancing world of healthcare technology, one must consider the intricate dynamics of Health Technology Assessment (HTA) Committees. These committees form a...

A significant advancement in pharmaceuticals is under review as the Agency for Health Technology Assessment and Tariff System (AOTMiT) evaluates the potential reimbursement of...

In the rapidly advancing field of genetics, Polygenic Risk Scores (PRS) stand out as a potentially transformative element in personalizing healthcare. However, the complexity...

In the rapidly evolving landscape of pharmaceutical approvals, Breakthrough Therapy Designation (BTD) programs have quickly become a focal point for expedited drug development processes...

Germany's healthcare system pioneers a new phase in early prostate cancer detection through a focus on innovative medical assessment methods. As this shift unfolds,...

The Molecule Independent Device Bridging Approach (MIDBA) with YpsoMate represents a significant milestone in drug delivery innovations. Unlike traditional methodologies, MIDBA opts for an...

In a bid to confront the challenges surrounding access to advanced therapies for rare disease patients, the first RAREMED Congress in Colombia brought together...

Armed with a mandate to maintain the highest standards in national healthcare practices, the Gemeinsame Bundesausschuss (G-BA) has embarked on a critical assessment of...

In a move that underscores the important role of evidence submission in pharmacological approvals, the UK National Institute for Health and Care Excellence (NICE)...

The complexities surrounding the connection between the volume of medical procedures and the resulting quality of care are progressively emerging as significant concerns in...

The stakeholders in the medical community navigate the complex landscape of cancer treatment options with the release of the latest dossier assessment from the...